UT Erlanger Cardiology
Continuing the Tradition of Cardiac Innovation
The Region’s Only Academic Cardiology Group
UT Erlanger Cardiology practices evidence- based standards of academic cardiology and puts these standards to work for patients, every day.
The Region’s First Subcutaneous Cardioverter-Defibrillator
This breakthrough device protects against sudden cardiac arrest while leaving the heart and vasculature untouched.
A Leader in Radial Cardiac Catheterizations
Erlanger is a regional innovator with this minimally-invasive procedure through the wrist, which offers faster recovery and reduced bleeding.
National Quality Approval from the Joint Commission
UT Erlanger Cardiology is the region’s only provider to earn the Joint Commission’s highest accreditation for fast heart attack treatment.
- Atrial fibrillation
- Cardiac arrest
- Cardiac rehab
- Cholesterol disorders (hypercholesterolemia, hyperlipidemia, dyslipidemia)
- Congenital heart defects
- Heart attack (acute myocardial infarction)
- Heart failure
- Heart murmurs
- Heart valve problems and disease
- High blood pressure
- HIV-related heart issues
- Metabolic syndrome
- Peripheral artery disease (PAD)